1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile
(
- Contribution to journal › Article
-
Mark
Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
(
- Contribution to journal › Article
- 2023
-
Mark
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Argonaute, Vault, and Ribosomal Proteins Targeted by Autoantibodies in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
- 2022
-
Mark
Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Autoantibodies against the envelope proteins of endogenous retroviruses K102 and K108 in patients with systemic lupus erythematosus correlate with active disease
(
- Contribution to journal › Article
- 2021
-
Mark
De novo lupus nephritis during treatment with belimumab
(
- Contribution to journal › Article
- 2020
-
Mark
Type i IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero
(
- Contribution to journal › Article
-
Mark
Autoantibody and cytokine profiles during treatment with belimumab in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 2017
-
Mark
Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity
(
- Contribution to journal › Article